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Abstract
Background: Oligodendrocytes are specialized cells of the nervous system that produce the myelin sheaths surrounding the
axons of neurons. Myelinating the axons increases the speed of nerve conduction and demyelination contributes to the
pathology of neurodegenerative diseases such as multiple sclerosis. Oligodendrocyte differentiation is specified early in
development by the expression of the basic-helix-loop-helix transcription factor Olig2 in the ventral region of the neural
tube. Understanding how Olig2 expression is controlled is therefore essential for elucidating the mechanisms governing
oligodendrocyte differentiation. A method is needed to identify potential regulatory sequences in the long stretches of
adjacent non-coding DNA that flank Olig2.
Methodology/Principal Findings: We identified ten potential regulatory regions upstream of Olig2 based on a combination
of bioinformatics metrics that included evolutionary conservation across multiple vertebrate genomes, the presence of
potential transcription factor binding sites and the existence of ultraconserved elements. One of our computational
predictions includes a region previously identified as the Olig2 basal promoter, suggesting that our criterion represented
characteristics of known regulatory regions. In this study, we tested one candidate regulatory region for its ability to
modulate the Olig2 basal promoter and found that it represses expression in undifferentiated embryonic stem cells.
Conclusions/Significance: The regulatory region we identified modifies the expression regulated by the Olig2 basal
promoter in a manner consistent with our current understanding of Olig2 expression during oligodendrocyte
differentiation. Our results support a model in which constitutive activation of Olig2 by its basal promoter is repressed
in undifferentiated cells by upstream repressive elements until that repression is relieved during differentiation. We
conclude that the potential regulatory elements presented in this study provide a good starting point for unraveling the cis-
regulatory logic that governs Olig2 expression. Future studies of the functionality of the potential regulatory elements we
present will help reveal the interactions that govern Olig2 expression during development.
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Introduction
Oligodendrocytes are glial cells that myelinate axons, forming
the myelin sheaths in the central nervous system. These myelin
sheaths enhance the saltatory conduction by insulating the axons
and forming the nodes of Ranvier (reviewed in [1,2]). Damage to
myelin sheaths can result in devastating neuronal diseases, such as
multiple sclerosis [3]. Even though myelin is formed mostly during
postnatal development in mammals, the specification of oligoden-
drocytes cell fate occurs early in development [4]. Numerous
studies have shown that this specification of oligodendrocyte
progenitors depends on a single gene, Olig2(NM_016967) [5,6].
Olig2 is a basic-helix-loop-helix transcription factor and acts as a
transcriptional repressor [7,8]. It is structurally conserved from
humans to zebrafish [6,9]. Mice homozygous for Olig2 deletion do
not form oligodendrocytes, and die on the day of birth [6,10].
Olig2 misexpression has been associated with neuronal disorders,
including schizophrenia [11,12] and Alzheimer’s disease [13].
Thus manipulating Olig2 expression could have therapeutic
potential for some neurodegenerative diseases.
The expression of Olig2 is first detected in mice at E8.5 in the
ventral portion of the mouse neural tube [6,7]. This precedes the
expression of early oligodendrocyte precursor markers such as
platelet-derived growth factor receptor a, whose expression is first
detected at E12.5 [7]. Olig2 expression is maintained in mature
oligodendrocytes, but not in astrocytes, in the adult central
nervous sytem [14]. The basal promoter of Olig2 has been located
and is functional in cell types that do not express Olig2 [15]. A
motor neuron-specific enhancer has also been located downstream
of Olig2 based on transgenic mouse studies [16]. However, other
factors involved in the molecular events that regulate Olig2
expression remain to be elucidated.
To further our understanding of the mechanisms by which Olig2
expression is regulated, we identified potential regulatory regions
upstream of the Olig2 coding region using criteria such as
clustering of potential transcription factor binding sites and
sequence conservation. We then verified one of these predictions
by testing its effect on the expression of an Olig2 reporter gene in
mouse embryonic stem cells. Embryonic stem (ES) cells are an
attractive tool for biomedical research since they have the
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precursors, in vitro [17–19]. Furthermore, the earliest stages of
oligodendrocyte development in ES derived neuroepithelial cells
follow a similar ordered sequence to that observed in vivo [15,20–
22]. ES cell derived oligodendrocytes also interact with host
neurons and myelinate axons in the brain [23,24]. By studying the
effect of potential regulatory elements in both undifferentiated and
differentiated states, we will be able to gain a better understanding
of the regulation of Olig2. We suggest that bioinformatic
identification of potential cis-regulatory elements coupled with
rapid experimental verification in ES cells will provide a powerful
combination for elucidating the transcriptional control of major
developmental regulators.
Results
Potential regulatory regions identified computationally
The 150 kb sequence upstream of Olig2 region has been shown
to be sufficient to drive normal expression of Olig2 [20]. We sought
to identify the regulatory elements in this region, reasoning that
potential regulatory elements were likely to share some of the
following properties: high sequence conservation relative to
orthologous sequences from other vertebrate genomes, stretches
of sequence that are perfectly conserved between orthologous
regions from mammalian genomes, and, high densities of potential
transcription factor binding sites (TFBS) [25–30]. We therefore
devised metrics to score these properties in the upstream region of
Olig2.
In order to identify regions upstream of Olig2 that are dense in
potential TFBS, we removed 57 kb of repeated sequence, leaving 93
kb of sequence in the analysis. We used the program Patser [31,32]
to identify sequences that match the Position WeightMatrix (PWM)
models of all known mammalian TFBS from TRANSFAC [33].
TheTFBSdensityin2 kbregionswasdefined asthetotalnumberof
base pairs contained in TFBS. The top 6% of windows contain at
least 230 bp of TFBS (Figure 1A and Figure S1).
We located evolutionarily conserved regions by calculating the
percent identity in all 2 kb regions spanning the Olig2 promoter
using multiple alignments of seventeen species: mouse, rat, rabbit,
human, chimp, macaque, dog, cow, armadillo, elephant, tenrec,
opossum, chicken, frog, zebrafish, tetraodon and fugu. The
average percent identity per 2 kb region is 35%. The top 8% of
windows have an average percent identity of at least 75%.
(Figure 1B and Figure S1).
We also searched for ultraconserved elements in regions
upstream of Olig2. Ultraconserved elements were first defined as
sequences at least 200 bp long that show perfect conservation in
alignments of the human, mouse and rat reference genomes (perfect
HMR conservation). They have been hypothesized to represent
sequencesunderselectionforspecificfunctions[34,35] .The200bp
threshold used to define these elements is arbitrary and we therefore
sought to determine empirically what the appropriate threshold
length should be for defining a sequence as ultraconserved. To build
an expected length distribution of segments with perfect conserva-
tion, we assumed that the identity of each base was independent of
all other bases and randomly swapped the columns in alignments of
non-coding portions of the three genomes. For each length, we
tabulated the number of perfectly conserved sequences from the
simulation and compared it to the observed number of segments in
the actual alignments (Figure 2). A sequence with 38 bp of perfect
HMR conservation was statistically significant (280 segments
expected, 8031 observed, false positive rate,0.05). Using this
threshold, we found sixteen such sequences upstream of Olig2 (range
38–106 bp) (Table 1 and Figure S1).
The analyses described above identified 2 kb sequence windows
upstream of Olig2 that either contained a high density of potential
TFBS, showed high conservation across many vertebrate ge-
nomes, or showed stretches of perfect HMR conservation. We
combined these sets of sequences to identify potential regulatory
regions (Table 2, Table S2). Some regions that did not included
stretches of identical bases, but were otherwise highly conserved,
were also included.
The Olig2 basal promoter has been shown to reside in the 2 kb
region immediately upstream of the Olig2 exons [15,20]. This
region also appeared on our candidate list (mm8_chr16: 91,112,409
–9 1 , 114,408; Table 2), suggesting that our criterion represented
characteristics of known regulatory regions. This 2 kb region
contains 237 bases covered by potential TFBS, many of which
were binding sites for Sp1. Sp1 is a transcription factor that
activates gene expression [36,37]. In addition, this region has
Figure 1. A) Frequency distribution of potential transcription factor binding sites in 2 Kb windows across the Olig2 upstream
region. Sequences upstream of Olig2 were scanned using Patser [31,32] for any potential binding site for any of the mammalian transcription factors
in TRANSFAC [33]. Total lengths of potential TFBS were summed up for each 2 kb window. B) Frequency distribution of percent identity in the
Olig2 promoter. The average percent identity was calculated for every 2 kb window spanning the multiple alignments of sixteen species in the
regions upstream of Olig2.
doi:10.1371/journal.pone.0003946.g001
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sequence of perfect HMR conservation.
Another region on our candidate list (mm8_chr16: 91,080,626 –
91,082,625; Table 2) may contain a repressive element (DIG,
unpublished data). This region shows 83.7% conservation across
multiple genomes, the highest in the Olig2 promoter, and includes
a 45 bp sequence of perfect HMR conservation. A recent study
demonstrated that this region has different methylation patterns in
ES cells and neuronal precursor cells [38]. Furthermore, this
region contains numerous binding sites for Gut-Kruppel-Like
Factor 4 (Gklf4). Recent studies have shown that Gklf4 is one of
four transcription factors required to induce pluripotent stem cells
from mouse fibroblasts [39]. There is also evidence that Gklf plays
important roles in ES cells, such as in inhibiting myofibroblast
differentiation [40] and regulating the expression of Lefty1 [41].
We therefore suspect that Gklf4 plays a similar role in regulating
oligodendrocyte differentiation by repressing Olig2 expression in
undifferentiated cells.
In addition, another region on our candidate list
(mm8_chr16:91,061,447 – 91,063,446, Table 2) was shown to
have different methylation patterns between ES cells and neuronal
precursor cells [38]. This region contains three segments of perfect
HMR conservation with a combined length of 121 bp. It has
75.2% identity across all genomes in the alignment and contains
221 bp of potential TFBS. We also speculate that this region
contains sequences that regulate Olig2 expression.
Our top candidate for a new regulatory region (mm8_chr16:
91,028,363-91,030,362; Table 2) contained a sequence we
designated as ULTRA (chr16 91,029,26-91, 029,835, Table S2).
Figure 2. Expected and observed length distribution of non-
coding sequences with perfect conservation across human,
mouse, and rat reference genomes of Olig2. The expected length
distribution was generated by randomizing the columns in the human,
mouse, and rat multiple alignments containing only non-coding
regions.
doi:10.1371/journal.pone.0003946.g002
Table 1. Perfectly conserved sequences upstream of Olig2.
Start Coordinate
(Feb 2006)
Stop Coordinate
(Feb 2006) Length (bp)
90,986,285 90,986,328 44
90,994,033 90,994,087 55
90,994,103 90,994,146 44
90,994,165 90,994,225 61
90,994,290 90,994,338 49
90,994,531 90,994,576 46
91,014,404 91,014,444 41
91,029,418 91,029,523 106
91,029,525 91,029,569 45
91,062,100 91,062,137 38
91,062,232 91,062,269 38
91,062,462 91,062,506 45
91,081,445 91,081,489 45
91,097,962 91,098,002 41
91,098,179 91,098,216 38
91,112,651 91,112,711 61
Sequences showing perfect identity over at least 38 bp across human, mouse,
and rat reference genomes are identified in the Olig2 promoter. This length
threshold of 38 bp was selected based on a comparison between expected and
observed length distributions of perfectly non-coding conserved segments
across the entire genome alignments.
doi:10.1371/journal.pone.0003946.t001
Table 2. Putative regulatory regions in the Olig2 promoter.
Start Coordinate
(Feb. 2006, mm8)
Stop Coordinate
(Feb. 2006, mm8)
Average percent
identity
Total length of Potential
transcriptional factor binding
sites (both strands, bp)
Total length of segments with perfect
conservation (bp) [number of segments]
90,982,736 90,984,735 0.708 264 0
90,987,057 90,989,057 0.778 191 0
90,992,944 90,994,943 0.826 236 255 [5]
91,002,382 91,004,381 0.780 243 0
91,028,363 91,030,362 0.803 225 151 [2]
91,051,171 91,053,170 0.762 260 0
91,061,447 91,063,446 0.752 221 121 [3]
91,080,626 91,082,625 0.837 230 45 [1]
91,097,264 91,099,263 0.710 301 79 [2]
91,112,409 91,114,408 0.747 237 61 [1]
Top candidates contain stretches of perfectly conserved sequences from human, mouse, and rat alignments, are highly conserved across at least four species, and
contain large number of TFBS.
doi:10.1371/journal.pone.0003946.t002
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conservation, which are separated by only a 1 base mismatch in
the human genome. This region also has 80.3% conservation
among the set of seventeen vertebrate genomes and was
significantly enriched for potential TFBS. In addition, ULTRA
shows 71% sequence similarity with another region
(mm8_chr10:18,999,620-18,999,731) that also shows perfect iden-
tity among human, mouse, and rat genomes. This second region is
located 46 kb upstream of Olig3, a paralogous gene of Olig2. The
presences of these similar highly conserved elements in the
promoters of two genes in the Olig family suggest that these
elements play a role in Olig gene expression. We, therefore, tested
whether ULTRA could influence the expression regulated by the
Olig2 promoter in the current study.
ULTRA represses Olig2 basal promoter regulated
expression in embryonic stem cells
We constructed three plasmids (P-plasmid, UP-plasmid, PGK-
plasmid) to test the regulatory activity of ULTRA (Methods). All
three constructs all included a neomycin cassette, which confers
resistance to G418, and the coding region of green fluorescent
protein (GFP), but differed in the sequences upstream of GFP. The
Olig2 basal promoter sequence was placed upstream of GFP in P-
plasmid. The UP-plasmid is identical to the P-plasmid except that the
ULTRA sequence is included directly upstream of the Olig2 basal
promoter, and is designed to test whether the ULTRA region can
modulate the activity of the Olig2 basal promoter. The
phosphoglycerate kinase promoter was placed upstream of GFP
in PGK-plasmid to serve as a positive control.
The three constructs were separately transfected into mouse ES
cells and random integration events were selected for using G418.
The resulting cell lines were designated P-clones, UP-clones, and
PGK-clones. Polymerase chain reaction (PCR) was used to verify
that the complete sequences including the promoter and the GFP
were integrated into the genome (data not shown). We kept only
clones with intact target sequences, resulting in 28 P-clones 48 UP-
clones and 26 PGK-clones. These clones were grown on STO feeder
cells and then assayed by flow cytometry to measure GFP
expression. To distinguish ES cells from these STO cells in each
culture, we incubated all cells with a monoclonal antibody to
mouse SSEA-1 (Stage-specific embryonic antigen-1), which is
expressed on the surface of ES cells, but not on STO cells. The
binding events of SSEA-1 antibody were detected using an anti-
mouse secondary antibody conjugated to Alexa Fluor 555. The
fluorescent levels of GFP and the Alexa Fluor 555 antibodies for
each clone, along with the sizes of individual cells, were
simultaneously detected on a flow cytometer. We included four
wells of STO cells and four wells of ES cells as controls. These
controls were used to build a statistical model to distinguish ES
cells from non-ES cells in PGK-clones. We built a logistic regression
model to predict cell type (ES vs non-ES) with three variables:
antibody fluorescence, cell granularity measured by side scatter
values, and the plate in which the clone was located. With this
model, we first assessed the GFP expression of PGK-clones. The
GFP expressions of PGK-clones range from 87.76 to 656.90
arbitrary fluorescent units (AFU) after adjusting for background
fluorescence, indicating that the GFP sequence was functional and
that integration sites in the genome indeed influence expression.
We chose one PGK-clone with the smallest standard deviation in
GFP expression to include on plates containing the P- and UP-
clones. This PGK-clone serves as a technical positive control for each
plate. We also used a similar logistic regression to differentiate
between ES and non-ES cells in P- and UP-clones. With this model,
a threshold of 0.48 was used to differentiate between ES and non-
ES cells. This threshold correctly predicted 92% ES cells and 97%
of STO cells in the control wells. This model was applied to all P-
and UP-clones and only cells deemed to be ES cells were kept for
further analysis. After removing all the non-ES cells from each
clone, the average number of cells per P-clone is 151,217 cells,
ranging from 58,770 to 196,069 cells. The number of cells per UP-
clone ranged from 47,182 to 193,392 cells with an average of
134,618 cells per clone. The mean GFP expression for P-clones was
335 AFU, whereas the mean GFP value for UP-clones was 258
AFU, after correcting for background fluorescence (Figure 3).
The reduction in GFP expression in the UP-clones relative to the P-
clones was statistically significant (P value,0.05, Wilcoxon rank
sum test), suggesting that ULTRA represses the expression driven
by the Olig2 basal promoter.
Figure 3. A) Distribution of fluorescence intensity in 28 P-clones in the undifferentiated state. B) Distribution of fluorescence
intensity in 48 UP-clones in the undifferentiated state. P- and UP-clones were created by transfecting ES cells using two different constructs:
one with a basal Olig2 promoter upstream of GFP and the other with ULTRA placed in front of the Olig2 promoter and GFP. Integration events were
selected by applying neomycin. Clones were expanded and analyzed for GFP expression by flow cytometry. The distributions of fluorescence
intensity for P- and UP-clones were statistically different (P-value,0.05, Wilcoxon rank sum test).
doi:10.1371/journal.pone.0003946.g003
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expression in differentiated neural precursor cells
We investigated the possibility that this ULTRA also affects
expression driven by the Olig2 basal promoter in differentiated cells.
We differentiated all 76 ES clones into neural precursor cells by
treating them with retinoic acid and a Sonic Hedgehog agonist. 25 P-
clonesand 46UP-clonessurvived differentiation. Differentiationinduces
Olig2 e x p r e s s i o na n dd i f f e r e n t i a t e dc e l l sw e r es e l e c t e db a s e do n
labeling with Olig2 antibodies. We assayed GFP fluorescence and
Olig2 staining for each clone using a flow cytometer. We defined
differentiated cells from each clone as those with higher Olig2
antibody fluorescence values than the undifferentiated ES cells. We
computed their average GFP expression of each differentiated clone
by subtracting the background fluorescence determined from the
controlwellsonthesameplate.ThemeanGFPexpressionforP-clones
was 70.3 AFU and for UP-clones was 66.2 AFU (Figure 4).T h e
difference in GFP was not statistically significant (P value .0.05,
Wilcoxon rank sum test), indicating that ULTRA d o e sn o ta f f e c tt h e
expression driven by the Olig2 basal promoter in neuronal precursors.
Discussion
Despite mounting evidence that the regulation of Olig2 at the
level of transcription plays an important role in glial cell fate
specification, we know little about the regulation of Olig2. Here we
presented a preliminary study aimed at identifying cis-regulatory
regions that control Olig2 expression. Since distal cis-regulatory
elements in vertebrates can be located far from the gene [42], we
scanned the 150 kb of Olig2 upstream sequence and identified ten
regions containing potential regulatory elements which might play
a role in controlling Olig2 gene expression. Here we verified one
candidate region in mouse ES cells and neuronal precursor cells.
Our results indicate that this region contains sequences that
repress Olig2 expression in undifferentiated cells. In neuronal
precursor cells, this region does not appear to repress Olig2
expression. This element may play an important role in keeping
Olig2 expression off in undifferentiated ES cells. Future studies,
such as deleting this region from its native locus, are needed to
further elucidate the molecular roles of this region.
Our results suggest a model by which Olig2, a key developmen-
tal transcription factor, is expressed only in cells developing along
the neural lineage. The basal promoter of Olig2 shows constitutive
activity in both undifferentiated ES cells and neuronal precursors
[15,20], indicating that the basal promoter alone cannot explain
Olig2 expression. The expression of Olig2 is likely repressed in
undifferentiated cells through the concerted action of upstream
repressive elements including the ULTRA and, possibly, two other
regions [38]. This repression is then relieved as cells develop along
the neuronal lineage allowing Olig2 expression. The predictions of
this model are testable and provide a framework for further studies
of Olig2 expression regulation.
The recent discovery of ultraconserved elements [34] has
generated a debate on the extent to which sequence conservation
reflects functional importance. Ultraconserved elements are more
conserved than coding sequences, thus prompting the suggestions
that they encode essential functions. Here we used an empirically
defined threshold to identify elements with perfect identity that we
would not expect to arise randomly throughout evolution. The
ULTRA region we tested in this study contains two such elements,
but the region only has a mild repressive effect on expression.
These results are in agreement with our previous study, which
demonstrated that selection on these elements with contiguous
identity is only weakly purifying [35].
We identified ten potential regulatory regions of Olig2 using a
combination of sequence conservation across seventeen vertebrate
genomes and TFBS density, and perfect HMR conservation. Only
one of these candidate regions, the Olig2 basal promoter, had
previous, direct experimental support to suggest that it regulates
Olig2 expression [15,20]. Two candidate regions have methylation
profiles that suggest a regulatory role. Here we present direct
evidence that a fourth candidate region, ULTRA, modifies the
expression regulated by the Olig2 basal promoter in a manner
consistent with our current understanding of Olig2 expression
during oligodendrocyte differentiation. This study provides a basis
for studying Olig2 regulation on the molecular level. We anticipate
that further studies on our predicted regulatory regions will
continue to unravel the regulatory interactions governing the
timing and location of Olig2 expression during development.
Materials and Methods
Computational Predictions of Regulatory Elements
We predicted regulatory elements using three criteria: density of
potential transcription factor binding sites (TFBS), sequence
Figure 4. A) Distribution of fluorescence intensity in 25 P-clones in the differentiated state. B) Distribution of fluorescence intensity
in 46 UP-clones in the differentiated state. ES cells were grown in suspension to form embryonic bodies and retinoic acid and Shh agonist Hh-Ag
1.4 were added to the medium after 2 days. Differentiated cells were detected using Olig2 antibodies. The distributions of differentiated P- and UP-
clones were not statistically different (P value .0.05, Wilcoxon rank sum test).
doi:10.1371/journal.pone.0003946.g004
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with perfect conservation in human, mouse, and rat reference
genomes.
The 150 kb sequence upstream of the mouse Olig2 gene was
downloaded from the UCSC Genome Browser with nucleotides in
repeat regions masked (mm8_90,964,409-91,114,408) [47]. We
used Patser [31,32] to scan this region for any potential binding site
for any of the 263 mammalian transcription factors in TRANS-
FAC [33]. The numbers of potential sites overlapping each
nucleotide position were summed up for individual bases and then
the density of potential binding sites for each 2 kb window along
the 150 kb upstream of the Olig2 coding sequences by adding up
the number of sites at each base in the window.
To identify highly conserved regions, multiple sequence
alignments with seventeen species spanning 150 kb upstream
regions of Olig2 were downloaded from the UCSC Genome
Browser [47]. The seventeen species include mouse, rat, rabbit,
human, chimp, macaque, dog, cow, armadillo, elephant, tenrec,
opossum, chicken, frog, zebrafish, tetraodon and fugu. To narrow
down the conserved regions in this set of alignments, the percent
identity for each base found in the mouse genome was calculated
using the following scoring scheme: a percent identity of zero was
assigned to a base if fewer than three species, other than mouse,
contained a nucleotide in that position; otherwise, the percent
identity is calculated by dividing the total number of species having
the major allele by the total number of species having a non-gap
base in that position. We then calculate the average percent
identity for overlapping windows of 2 kb along the Olig2 promoter.
The third criterion we used to predict the regulatory elements is
the presence of sequences with uninterrupted perfect identity across
human, mouse and rat, so-called ultraconserved elements. We
empirically determined the length threshold for a significant run of
perfectly conserved adjacent residues across human, mouse and rat
genomes. We used the same human-mouse-rat alignments that
Bejerano et al. [34] used in first identifying the ultraconserved
elements to generate the empirical length distribution. We removed
allexonicsequencesfromthealignmentsandthen randomized non-
gapped columns in each alignment. After each round of
randomization, the frequencies of lengths of perfectly matched
sequences were recorded. Ten complete randomizations were done
across all alignable regions of the three genomes and the resulting
frequencies were averaged to create the empirical length distribu-
tion of perfectly conserved sequences. We selected the threshold
length, 38 bp, by using a false positive rate of 0.05 derived from
comparing the expected distribution with the observed. A false
positive rate was calculated as the number of expected segments
divided by the number of observed segments of the samelength. We
then scanned the 150 kb upstream sequence of Olig2 for any
identical sequence across human, mouse, and rat genomes whose
length was equal or greater than the threshold length.
The top candidate regions with potential regulatory functions
were selected such that they contained perfectly matched
sequences, were highly conserved among all species in the
alignment and had dense transcription factor binding sites.
Regions were also considered as candidates when they included
high numbers of binding sites and were highly conserved only. In
total, ten regions of 2 kb each were identified as potential
regulatory regions.
Construction of Enhancer Plasmids
We chose one computational prediction to validate experimen-
tally in mouse embryonic stem (ES) cells: mm8_chr16: 91,028,363
—9 1 ,030,36. To test whether this region contained any element
that has enhancer activity, the most conserved sequence within
this region, mm8_chr16: 91,029,261 — 91, 029,835 (designated
ULTRA), was chosen to test for its activity in ES cells. We
constructed three plasmids from the pEGFP plasmid (Clontech): a
plasmid with a native promoter from the Olig2 locus in front of the
green fluorescence protein (GFP) gene (P-plasmid), a plasmid with
ULTRA cloned in front of the native promoter, followed by the
GFP gene (UP-plasmid), and a plasmid with the phosphoglycerate
kinase as promoter in front of the GFP gene (PGK-plasmid).
The P-plasmid was constructed by cloning the 2 kb sequence in
front of the first exon of Olig2 (mm8_chr16:91,112,391 —
91,114,400) upstream of the GFP gene on the pEGFP plasmid.
This sequence was shown to contain the Olig2 basal promoter
[15,20]. The sequence was amplified from the mouse genome
using primers listed in Table S1. The polymerase chain reaction
(PCR) products and the pEGFP plasmid were both digested with
BamHI and Sal1 restriction enzymes. Ligation was carried out at
16uC for one hour. The UP-plasmid was constructed by inserting
the ULTRA upstream of the 2 kb segment. The ULTRA was
amplified from the mouse genome using appropriate primers
(Table S1). The PCR product and the P-plasmid were then
digested with BglII and HindIII restriction enzyme and ligated at
16uC for one hour. The PGK-plasmid was constructed by putting
the phosphoglycerate kinase as a promoter upstream of GFP. The
phosphoglycerate kinsase sequence was digested from pBC293
(Cohen Lab, Washington University) using EcoRI and BglII
restriction enzymes. The pEGFP vector was then digested with
these two enzymes and the ligation reaction was carried out at
16uC in one hour. Transformation of E. coli was selected with
30 mg/mL kanamycin.
Embryonic stem cell culture and transfection
The ES cells used in this study were the mouse RW4 line and
were cultured in conditions previously described [20]. About 5 ug of
P-plasmid, UP-plasmid, and PGK-plasmid were used in independent
electroporations to created P-clones, UP-clones and PGK-clones.
Electroporations were carried out using program A-013 on a
Nucleofector II device (Amaxa Inc.) with the provided ES cell
electroporation solution. Electroporated cells were transferred to a
100 mm gelatinized dish with 10 mL of complete medium (CM)
(DMEM+10% fetal bovine serum, 10% newborn calf serum and
nucleoside supplement) with 1000 U/mL leukemia inhibitory factor
(LIF), 0.1 mM b-mercaptoethanol [22]. 50 uL of 250 ug/mL of
G418 (GIBCO) was added to the tranfected cells to select for cells
with a stably integrated transgene. After eight days, clones resistant
to G418 were transferred into 96-well plate wells with about 30,000
STO cells as feeder layers. STO cells had been irradiated with 3500
rads to prevent replication. ES cell clones were then cultured and
expanded in CM as described until each clone could be maintained
and harvested from a well on a six-well plate [20].
PCR verification of integration events
The cells were washed with Dulbecco’s solution A (PBS),
dissociated with 380 uL 0.25% Trypsin-EDTA (GIBCO), and
harvested from six-well plates. DNA was extracted from cells using
a DNA purification kit (5 PRIME ArchivePure, Fisher Scientific).
To verify the complete sequence from the beginning of the
promoter to the end of the GFP gene on the P-plasmid was
integrated into the genome, two separate PCR reactions were
performed using two primer pairs (Table S1). Similarly, UP-clones
and PGK-clones were verified via PCR reactions (Table S1).
Plate layout and antibody staining
Each clone was placed into a well on a 96-well plate and GFP
expression in clones was assessed by flow cytometry. To control for
Olig2 Expression
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A12, H1–H3, H10–H12) were used as control wells on each 96-
well plate. Each set of three control wells contained either STO
cells, RW4 cells, or PGK-clone cells, in that order. The PGK-clone
was used as a positive control. Each clone with approximately four
to five million cells were washed with PBS, dissociated with 380 uL
0.25% Trypsin-EDTA, and recovered with 1.6 mL CM. Each
clone was then spun down at 1200rpm for 5 min, resuspended in
100 uL PBS, and transferred into a well on a 96-well plate. Each
clone was washed with 100 uL PBS twice. The cells were then
incubated at 4uC with 50 uL of unconjugated mouse SSEA-
1(Stage-specific embryonic antigen-1) antibodies for 20 minutes
(Millipore, 1:50 dilution). SSEA-1 is present only on the cell
surface of ES cells, but not STO cells. After incubation, the cells
were washed twice with 100 uL PBS. We then stained with 50 uL
of anti-mouse IgM antibodies (Invitrogen, 1:100 dilution) for
20 minutes at 4uC. These secondary antibodies were conjugated
to Alexa Fluor 555. The cells were washed twice with 100 uL PBS
and then resuspended in 150 uL of PBS for fluorescence analysis
on a flow cytometer.
Analysis of GFP Expression in undifferentiated cells by
flow cytometry
Linear and log values of fluorescence level at 510 nm (GFP
fluorescence) and 565 nm (fluorescence of Alexa Fluor 555
antibodies), as well as forward scatter (FS) and side scatter (SS)
values were obtained for each cell using a Beckmann-Coulter
Cytomics FC500 MPL with a 488-nm laser. The Alexa Fluor 555
antibodies bind to SSEA-1 primary antibodies, which recognize the
antigens that are present only on the surface of ES cells. To select
only the undifferentiated ES cells from each well, the fluorescence
values of antibodies gathered from the RW4 cells and STO cells in
all the control wells were used to construct a logistic regression
model, which gives the probability of a cell being an ES cell. With
the assumption that majority of the RW4 cells were undifferentiated
and STO cells were not ES cells, we expected the RW4 cells and
STO cells to show different distributions of antibody fluorescence
values. We chose the best model, based on the lowest Akaike
information criterion (AIC) [48], to predict the membership of each
cell (a ES cell or non-ES cell). Parameters tested in the model
included: Plate effect, log(antibody fluorescence), log(FS), log(SS), antibody
fluorescence, FS,a n dSS values. We conducted leave-one-out cross
validations to assess the sensitivity and specificity of the model.
Sensitivity was defined as the number of correctly predicted ES cells
divided by the total number of true ES cells. Specificity was defined
as the number of correctly predicted non-ES cells divided by the
total number of true non-ES cells. We chose a threshold value for
selecting ES cells based on the sum of sensitivity and specificity
values. To investigate whether the location of each clone on a plate
affects the fluorescence levels of cells, models built using only three
sets of the STO-RW4 control wells were used to predict the cell
types of cells in the set of control wells that were not included in the
models. The sensitivity and specificity of the predictions were then
compared among the four different sets of wells. The appropriate
logistic regression model was used to select the undifferentiated cells
from each clone on the plates. To test whether there is a difference
in the distribution of mean GFP fluorescence levels among P-and
UP-clones, the Wilcoxon rank sum test was used.
Differentiation of ES cells
ES cells were treated with a protocol that induces ventral neural
cell fates. ES cells are first scrapped off the bottom of flasks and
cultured for two days in M-DFK5 medium [20]. After two days,
embryonic bodies were plated in a 24-well plate in the same media
in the presence of 2 mM retinoic acid (Sigma) and 30 nM of Shh
agonist Hh-Ag 1.4 (Curis) for 4 days.
Plate layout and antibody staining
We reserved four sets of three wells on each plate to serve as
controls. Each set of control wells contained a well of
undifferentiated RW4 cells, differentiated RW4 cells, and
differentiated TG25 ES cells. TG25 cells carry a GFP knock-in
at the Olig2 genes; GFP in the cells is turned on when they were
differentiated [49], thus serving as a positive control. The cells
were moved from 24-well plates to 96-well plates prior to staining
by using the procedures described earlier. After washing with PBS
twice, we fixed the cells with 4% paraformaldehyde for 30 minutes
at room temperature. We then permeated the cells with 0.1%
triton-X for 10 minutes and blocked the cells with bovine serum
albumin for 30 minutes. Cells were washed with PBS between
each step. We stained the cells with Olig2-antibodies (Chemicon,
1:100 dilution) for 30 minutes at 4uC. The second staining was
done using the Alexa Fluor 555 goat anti-rabbit IgG (H+L)
antibody (Invitrogen, 1:100 dilution) and incubated for 30 minutes
at 4uC. These conjugated secondary antibodies bind to Olig2-
antiboies. After staining, the cells were then resuspended in 150 uL
of PBS for fluorescence analysis on a flow cytometer.
Analysis of GFP Expressions in differentiated cells by flow
cytometry
To select only the differentiated cells from each well, the
fluorescence values of Alexa Fluor 555 antibodies emitted from the
undifferentiated and differentiated RW4 cells on each place were
used. The mean and standard deviation of the antibody
fluorescence from the undifferentiated RW4 cells were calculated.
The 95% confidence intervals were used as a threshold to
distinguish differentiated cells from undifferentiated cells. Any cell
with a fluorescence value higher than the 95% upper bound was
deemed differentiated. This threshold was applied to all clones on
a plate and GFP fluorescence was calculated for the differentiated
cells only. The average GFP values for the differentiated RW4
cells were subtracted from the GFP values for each clone on the
same plate to control for plate-to-plate variation. We used the
Wilcoxon rank sum test to test for differences in the distribution of
mean GFP fluorescence levels among P-and UP-clones.
Supporting Information
Figure S1 Potential transcriptional factor binding sites (TFBS)
density, conservation level and perfectly conserved human-mouse-rat
sequences in Olig2 promoter. The locations of potential TFBS were
identified using the program Patser [31,32] and all known
mammalian transcriptional factor matrices in TRANSFAC [33].
The level of conservation was calculated using multiple alignments of
seventeen vertebrate genomes. Sequences with at least 38 bp of
contiguous perfect conservation across the human, mouse, and rat
genomes were also located in the Olig2 promoter. Bases are colored
according to the level of conservation and the number of potential
TFBS located. Bases with high sequence conservation or contain high
number of potential TFBS are represented by darker blue whereas
bases with low sequence conservation or contain low number of
potential TFBS are represented by lighter blue. Candidate regions
with regulatory potentials are indicated with red boxes.
Found at: doi:10.1371/journal.pone.0003946.s001 (1.55 MB TIF)
Table S1 List of Primers
Found at: doi:10.1371/journal.pone.0003946.s002 (0.03 MB
DOC)
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Found at: doi:10.1371/journal.pone.0003946.s003 (0.09 MB
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